This story was updated 4 June to reflect the Lancet study’s retraction. Enrollment of new patients in the hydroxychloroquine (HCQ) arm of the World Health Organization’s Global COVID-19 Solidarity Trial will be put on pause, as the trial’s oversight committee reviews all available data on COVID-19 and hydroxychloroquine, WHO Director-General Dr. Tedros Adhanom Ghebreyesus said […] Continue reading ->
A COVID-19 vaccine candidate made by Chinese researchers successfully induced the development of neutralizing and binding antibodies against SARS-CoV-2, the virus that causes COVID-19, according to early results from a non-randomized phase I clinical trial published Friday in The Lancet.  The trial results follow on to results announced by Moderna earlier this week, which found […] Continue reading ->
This story was updated 4 June to reflect the paper’s retraction. New research published in The Lancet on Friday found that hydroxychloroquine and chloroquine has ‘no benefit’ for coronavirus patients, and could even increase the risk of heart arrhythmias and mortality.  The study was retracted by three of its authors on June 4, due to […] Continue reading ->
Countries that reopen while COVID-19 is still circulating widely will likely face strong waves of virus resurgence, and then have to reinstate severe lockdown measures. However, the cyclical relaxation and reinstatement of some public health measures, such as bans on mass gatherings or school closures, may also be normal as countries learn how to track […] Continue reading ->
Life expectancy has increased, particularly in low income countries, but COVID-19 threatens to throw progress off track, according to the World Health Organization’s annual roundup of worldwide disease and mortality trends. “The good news is that people around the world are living longer and healthier lives. The bad news is the rate of progress is […] Continue reading ->
Amidst the global shortage of ventilators, personal protective equipment, and diagnostics; sedatives, used to keep severe COVID-19 patients who require invasive ventilation continuously sedated, are in increasingly short supply around the United States. The US Food and Drug Administration (FDA) on Monday issued an emergency use authorization (EUA) for Fresenius Propoven 2% (propofol 20 mg/mL) […] Continue reading ->
As countries cautiously begin to lift lockdown measures, WHO Executive Director for Health Emergencies Mike Ryan has again warned that serological studies were presenting increasing evidence that a ‘herd immunity’ approach to mitigating the effects of further waves of infection would not be effective.  Herd immunity occurs when a large enough proportion of the population […] Continue reading ->
As reports of COVID-19 patients presenting with cardiovascular symptoms continue to surface, World Health Organization experts say more research is needed to understand all of the clinical presentations of the new disease. Still, they underlined that the new coronavirus primarily causes respiratory disease. “It is clear that in a proportion of patients, [COVID-19] is causing […] Continue reading ->